Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pfizer’s New Benchmark For New Era: 8% Annual Growth Is Sustainable

Dec 06 2004

• By The Pink Sheet

Related Content

Pfizer Sees 5% Growth In Second Half; Currency, Competition Hurt Sales

Jul 26 2004

Pfizer Confident That Caduet Will Succeed; How Safe Is Sales Force?

Oct 25 2004

Sales Force Bubble May Soon Burst; Slowing R&D Is Cause, Takeda Says

Dec 01 2003

Pfizer Caduet Launch Set For May; Inspra Starts Slow

Apr 26 2004

Pfizer Recognizes “Dark Side” Of Scale In R&D; No Sales Force Cuts Planned

Feb 16 2004

“Blockbuster” Launch Model Changing, Pfizer Says; Still Hope For Caduet

Jul 26 2004

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window